Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

被引：0
|
作者：
Tavara, B. [1 ]
Garrido, M. L. [1 ]
Rodriguez, Z. [1 ]
Rojas, M. [1 ]
Lopez, L. [1 ]
Medina, S. [1 ]
Ponte, C. [1 ]
Lopez, A. [1 ]
Sanchez, E. [1 ]
Pedraza, M. [1 ]
Vinals, P. [1 ]
Lopez, M. [1 ]
Alonso, D. [1 ]
Rodriguez, A. [1 ]
Davila, E. [1 ]
Castanon, C. [1 ]
De Sande, L. M. [1 ]
Nieto, B. [1 ]
Vallejo Pascual, M. E. [2 ]
Rodriguez, J. D. L. R. [1 ]
Garcia Palomo, A. [1 ]
Diz Tain, P. [1 ]
机构：
[1] Complejo Asistencial Univ Leon, Leon, Spain
[2] Univ Leon, Leon, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
DURVALUMAB; PACIFIC; REAL WORLD DATA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP05.02-0
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [41] Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)
    Saito, Go
    Oya, Yuko
    Taniguchi, Yoshihiko
    Kawachi, Hayato
    Daichi, Fujimoto
    Matsumoto, Hirotaka
    Iwasawa, Shunichiro
    Suzuki, Hidekazu
    Niitsu, Takayuki
    Miyauchi, Eisaku
    Yokoi, Takashi
    Yokoyama, Toshihide
    Uenami, Takeshi
    Sakata, Yoshihiko
    Arai, Daisuke
    Okada, Asuka
    Nagata, Kenji
    Teraoka, Shunsuke
    Kokubo, Masaki
    LUNG CANCER, 2021, 161 : 86 - 93
  • [42] REAL-WORLD DATA OF NIVOLUMAB IN NON-SMALL-CELL LUNG CANCER PATIENTS IN GREECE
    Kourlaba, G.
    Kokkotou, E.
    Papaspiliou, A.
    Stefanou, G.
    Stournara, L.
    Syrigos, K.
    VALUE IN HEALTH, 2019, 22 : S435 - S436
  • [43] Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone
    Abe, Takanori
    Saito, Satoshi
    Iino, Misaki
    Aoshika, Tomomi
    Ryuno, Yasuhiro
    Ohta, Tomohiro
    Igari, Mitsunobu
    Hirai, Ryuta
    Kumazaki, Yu
    Miura, Yu
    Kaira, Kyoichi
    Kagamu, Hiroshi
    Noda, Shin-ei
    Kato, Shingo
    THORACIC CANCER, 2021, 12 (02) : 245 - 250
  • [44] Who Benefits the Most From Adjuvant Durvalumab After Chemoradiotherapy for Non-small Cell Lung Cancer? An Exploratory Analysis
    Ohri, Nitin
    Halmos, Balazs
    Bodner, William R.
    Cheng, Haiying
    Garg, Madhur K.
    Gucalp, Rasim
    Guha, Chandan
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (02) : E172 - E179
  • [45] Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data
    Jang, Jeong Yun
    Song, Si Yeol
    Shin, Young Seob
    Kim, Ha Un
    Choi, Eun Kyung
    Kim, Sang-We
    Lee, Jae Cheol
    Lee, Dae Ho
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Su Ssan
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03):
  • [46] Real-world clinical characteristics and treatment of advanced non-small cell lung cancer (NSCLC) patients in China
    Shi, Yuankai
    Zhang, Xin
    Wu, Gang
    Xu, Jianping
    He, Yong
    Wang, Dong
    Huang, Cheng
    Chen, Mingwei
    Yu, Ping
    Yu, Yan
    Li, Wei
    Li, Qi
    Hu, Xiao-hua
    Sun, Guofang
    Li, Yulin
    Bu, Lilian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] The potential local service impact of durvalumab following concomitant chemoradiotherapy (cCRT) for patients with locally advanced non-small cell lung cancer (LA NSCLC)
    Girling, B.
    Bainbridge, H.
    McDonald, F.
    LUNG CANCER, 2018, 115 : S64 - S65
  • [48] Impact of age on chemoradiation (CRT) for locally advanced non-small cell lung cancer (NSCLC)
    Dallas, J. L.
    Sullivan, J. E.
    Riggs, C. E.
    Hou, W.
    LaPlant, K. D.
    George, T. J.
    Louzon, P.
    Lynch, J. W.
    Close, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [50] Sequential chemoradiotherapy versus radiotherapy in the management of locally advanced non-small-cell lung cancer
    Sharma, S
    Sharma, R
    Bhowmik, KT
    ADVANCES IN THERAPY, 2003, 20 (01) : 14 - 19
12345